160 related articles for article (PubMed ID: 22469134)
21. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
22. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
Li MY; Chong LC; Duns G; Lytle A; Woolcock B; Jiang A; Telenius A; Ben-Neriah S; Nawaz W; Slack GW; Elisia I; Viganò E; Aoki T; Healy S; Krystal G; Venturutti L; Scott DW; Steidl C
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2320421121. PubMed ID: 38662551
[TBL] [Abstract][Full Text] [Related]
23. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
24. An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression.
Zhang B; Calado DP; Wang Z; Fröhler S; Köchert K; Qian Y; Koralov SB; Schmidt-Supprian M; Sasaki Y; Unitt C; Rodig S; Chen W; Dalla-Favera R; Alt FW; Pasqualucci L; Rajewsky K
Cell Rep; 2015 May; 11(5):715-26. PubMed ID: 25921526
[TBL] [Abstract][Full Text] [Related]
25. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
Barth TF; Martin-Subero JI; Joos S; Menz CK; Hasel C; Mechtersheimer G; Parwaresch RM; Lichter P; Siebert R; Möoller P
Blood; 2003 May; 101(9):3681-6. PubMed ID: 12511414
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.
Steidl C; Telenius A; Shah SP; Farinha P; Barclay L; Boyle M; Connors JM; Horsman DE; Gascoyne RD
Blood; 2010 Jul; 116(3):418-27. PubMed ID: 20339089
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
28. Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma?
Martín-Subero JI; Knippschild U; Harder L; Barth TF; Riemke J; Grohmann S; Gesk S; Höppner J; Möller P; Parwaresch RM; Siebert R
Leukemia; 2003 Nov; 17(11):2214-9. PubMed ID: 14523479
[TBL] [Abstract][Full Text] [Related]
29. Allelic losses on chromosome 6q25 in Hodgkin and Reed Sternberg cells.
Re D; Starostik P; Massoudi N; Staratschek-Jox A; Dries V; Thomas RK; Diehl V; Wolf J
Cancer Res; 2003 May; 63(10):2606-9. PubMed ID: 12750286
[TBL] [Abstract][Full Text] [Related]
30. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
[TBL] [Abstract][Full Text] [Related]
31. Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.
Salipante SJ; Adey A; Thomas A; Lee C; Liu YJ; Kumar A; Lewis AP; Wu D; Fromm JR; Shendure J
Genes Chromosomes Cancer; 2016 Mar; 55(3):278-87. PubMed ID: 26650888
[TBL] [Abstract][Full Text] [Related]
32. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
[TBL] [Abstract][Full Text] [Related]
33. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
[TBL] [Abstract][Full Text] [Related]
34. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
35. BCL2 and BCL3 are recurrent translocation partners of the IGH locus.
Szymanowska N; Klapper W; Gesk S; Küppers R; Martín-Subero JI; Siebert R
Cancer Genet Cytogenet; 2008 Oct; 186(2):110-4. PubMed ID: 18940474
[TBL] [Abstract][Full Text] [Related]
36. A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines.
Feys T; Poppe B; De Preter K; Van Roy N; Verhasselt B; De Paepe P; De Paepe A; Speleman F
Haematologica; 2007 Jul; 92(7):913-20. PubMed ID: 17606441
[TBL] [Abstract][Full Text] [Related]
37. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
[TBL] [Abstract][Full Text] [Related]
38. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation.
Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P
Oncogene; 2006 Apr; 25(18):2679-84. PubMed ID: 16532038
[TBL] [Abstract][Full Text] [Related]
39. Notch and NF-κB signaling pathways in the biology of classical Hodgkin lymphoma.
Schwarzer R; Jundt F
Curr Mol Med; 2011 Apr; 11(3):236-45. PubMed ID: 21375490
[TBL] [Abstract][Full Text] [Related]
40. Non-canonical NF-κB signaling activation and regulation: principles and perspectives.
Razani B; Reichardt AD; Cheng G
Immunol Rev; 2011 Nov; 244(1):44-54. PubMed ID: 22017430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
